GcMAF & Nagalase
Re: What do you think about GcMAF?
Gc precursor vitamin D-binding glycoprotein macrophage activating factor is another “magic bullet” and “tunnel vision” cancer therapy.
ALL successful cancer therapies (and there are darn few of them) reduce Nagalase (alpha-N-acetylgalactosaminidase), the extracellular enzyme secreted by cancer cells during tumor invasion.
GcMAF may have limited value; for example, Dr. Toshio Inui, M.D., of the Saisei Mirai Clinic in Kobe, Japan, has had at least a few cancer remissions with GcMAF.
Meanwhile, why is GcMAF’s primary researcher hiding out?
Maybe one of my readers can score an interview with him …
Dr. Nobuto Yamamoto, M.D.
Socrates Institute for Therapeutic Immunology (founded by Dr. Yamamoto in 1994)
1040 66th Avenue
Philadelphia, PA 19126-3305
We need a dialogue with this venerable doctor, not monologues by bloggers many times removed from him.
An institute named after Socrates might remember that he famously said …
“You know, Phaedrus, that’s the strange thing about writing … they seem to talk to you as if they were intelligent, but if you ask them anything about what they say, from a desire to be instructed, they go on telling you just the same thing forever.”
This is also a flaw in my ongoing monologues, dear reader.
Vibrant Gal, Guru Angisetty, and I hope to swing open the doors of the Santa Barbara Sun Sync Science School of Self Healing as soon as possible to begin the dialogue.
All donations greatly appreciated …